Loading…

Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze

Antidepressants are usually prescribed for the treatment of depression but more recently have also been recommended for the treatment of anxiety disorders. The purpose of this study was to investigate the anxiogenic- or anxiolytic-like effects of an acute administration of antidepressants (serotoner...

Full description

Saved in:
Bibliographic Details
Published in:Behavioural brain research 2007-01, Vol.176 (2), p.202-209
Main Authors: Drapier, Dominique, Bentué-Ferrer, Danièle, Laviolle, Bruno, Millet, Bruno, Allain, Hervé, Bourin, Michel, Reymann, Jean-Michel
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c503t-5a10c4ff5babb4fcc4b5bd9ce4e5fd125490737f97befbde8a7d325607b8cafe3
cites
container_end_page 209
container_issue 2
container_start_page 202
container_title Behavioural brain research
container_volume 176
creator Drapier, Dominique
Bentué-Ferrer, Danièle
Laviolle, Bruno
Millet, Bruno
Allain, Hervé
Bourin, Michel
Reymann, Jean-Michel
description Antidepressants are usually prescribed for the treatment of depression but more recently have also been recommended for the treatment of anxiety disorders. The purpose of this study was to investigate the anxiogenic- or anxiolytic-like effects of an acute administration of antidepressants (serotonergic and noradrenergic compounds) in male Wistar rats submitted to the elevated plus-maze. Fluoxetine (2.5, 5, 10, 15 mg/kg), paroxetine (0.1, 0.5, 3, 12 mg/kg) and desipramine (2.5, 5, 10 mg/kg) or their vehicles were administered intraperitoneally 30 min prior to testing. Diazepam (0.5, 1.5, 2.5 mg/kg) was used as a positive comparator for anxiolytic effect. In comparison with control animals, the percentage of time the rats treated with fluoxetine (5 and 10 mg/kg) and paroxetine (3 and 12 mg/kg) spent in the open arms decreased. The percent of inactive time spent in the open arms also decreased in rats given fluoxetine (5 and 10 mg/kg) and paroxetine (12 mg/kg). Desipramine was inactive on all these parameters. In conclusion, acute treatment with fluoxetine and paroxetine, but not with desipramine, produced a pattern of anxiety behavior. Thus, the pharmacological mechanism appears to be due more to serotonergic than adrenergic neurotransmission. The elevated plus-maze exhibits good sensitivity for detecting anxiogenic effects of antidepressant drugs and the conventional parameters are sufficient and reliable for detecting such effects.
doi_str_mv 10.1016/j.bbr.2006.10.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68373955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166432806005304</els_id><sourcerecordid>68373955</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-5a10c4ff5babb4fcc4b5bd9ce4e5fd125490737f97befbde8a7d325607b8cafe3</originalsourceid><addsrcrecordid>eNqFkUtv3SAQRlHUKrlJ8wO6qbxpVvEtGDC2soqi9CFF6qZdkwEGlSu_CnbU5tcX61rKLl3Bh86MZg6EvGd0zyirPx32xsR9RWmd857S6oTsWKOqUknRviG7zNSl4FVzRs5TOlBKBZXslJwxRVvJqNiRx3vv0c6pGH0Bdpmx8N0y_sE5DHhdTBC3ewGDKxymMEXo1zwORYRcN2Oa0a1x_oUFdvgEa566JZU9POM78tZDl_ByOy_Iz8_3P-6-lg_fv3y7u30oraR8LiUwaoX30oAxwlsrjDSutShQeseqvBBVXPlWGfTGYQPK8UrWVJnGgkd-Qa6Ofac4_l7yULoPyWLXwYDjknTdcMVbKf8LslZWdVM1GWRH0MYxpYheTzH0EP9qRvXqXx909q9X_-tT9p9rPmzNF9Oje6nYhGfg4wZAstD5CIMN6YVrBBdC8MzdHDnMzp4CRp1swMGiCzH_l3ZjeGWMfzChpHw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19526828</pqid></control><display><type>article</type><title>Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Drapier, Dominique ; Bentué-Ferrer, Danièle ; Laviolle, Bruno ; Millet, Bruno ; Allain, Hervé ; Bourin, Michel ; Reymann, Jean-Michel</creator><creatorcontrib>Drapier, Dominique ; Bentué-Ferrer, Danièle ; Laviolle, Bruno ; Millet, Bruno ; Allain, Hervé ; Bourin, Michel ; Reymann, Jean-Michel</creatorcontrib><description>Antidepressants are usually prescribed for the treatment of depression but more recently have also been recommended for the treatment of anxiety disorders. The purpose of this study was to investigate the anxiogenic- or anxiolytic-like effects of an acute administration of antidepressants (serotonergic and noradrenergic compounds) in male Wistar rats submitted to the elevated plus-maze. Fluoxetine (2.5, 5, 10, 15 mg/kg), paroxetine (0.1, 0.5, 3, 12 mg/kg) and desipramine (2.5, 5, 10 mg/kg) or their vehicles were administered intraperitoneally 30 min prior to testing. Diazepam (0.5, 1.5, 2.5 mg/kg) was used as a positive comparator for anxiolytic effect. In comparison with control animals, the percentage of time the rats treated with fluoxetine (5 and 10 mg/kg) and paroxetine (3 and 12 mg/kg) spent in the open arms decreased. The percent of inactive time spent in the open arms also decreased in rats given fluoxetine (5 and 10 mg/kg) and paroxetine (12 mg/kg). Desipramine was inactive on all these parameters. In conclusion, acute treatment with fluoxetine and paroxetine, but not with desipramine, produced a pattern of anxiety behavior. Thus, the pharmacological mechanism appears to be due more to serotonergic than adrenergic neurotransmission. The elevated plus-maze exhibits good sensitivity for detecting anxiogenic effects of antidepressant drugs and the conventional parameters are sufficient and reliable for detecting such effects.</description><identifier>ISSN: 0166-4328</identifier><identifier>EISSN: 1872-7549</identifier><identifier>DOI: 10.1016/j.bbr.2006.10.002</identifier><identifier>PMID: 17095104</identifier><identifier>CODEN: BBREDI</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>Analysis of Variance ; Animals ; Antidepressants ; Anxiety ; Behavior, Animal - drug effects ; Behavioral psychophysiology ; Biological and medical sciences ; Desipramine - pharmacology ; Dose-Response Relationship, Drug ; Enzyme Inhibitors - pharmacology ; Ethological parameters ; Fluoxetine - pharmacology ; Fundamental and applied biological sciences. Psychology ; Male ; Maze Learning - drug effects ; Medical sciences ; Neuropharmacology ; Paroxetine - pharmacology ; Pharmacology. Drug treatments ; Plus-maze ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Psychopharmacology ; Rats ; Rats, Wistar ; Serotonin Uptake Inhibitors - pharmacology</subject><ispartof>Behavioural brain research, 2007-01, Vol.176 (2), p.202-209</ispartof><rights>2006 Elsevier B.V.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-5a10c4ff5babb4fcc4b5bd9ce4e5fd125490737f97befbde8a7d325607b8cafe3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18434443$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17095104$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Drapier, Dominique</creatorcontrib><creatorcontrib>Bentué-Ferrer, Danièle</creatorcontrib><creatorcontrib>Laviolle, Bruno</creatorcontrib><creatorcontrib>Millet, Bruno</creatorcontrib><creatorcontrib>Allain, Hervé</creatorcontrib><creatorcontrib>Bourin, Michel</creatorcontrib><creatorcontrib>Reymann, Jean-Michel</creatorcontrib><title>Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze</title><title>Behavioural brain research</title><addtitle>Behav Brain Res</addtitle><description>Antidepressants are usually prescribed for the treatment of depression but more recently have also been recommended for the treatment of anxiety disorders. The purpose of this study was to investigate the anxiogenic- or anxiolytic-like effects of an acute administration of antidepressants (serotonergic and noradrenergic compounds) in male Wistar rats submitted to the elevated plus-maze. Fluoxetine (2.5, 5, 10, 15 mg/kg), paroxetine (0.1, 0.5, 3, 12 mg/kg) and desipramine (2.5, 5, 10 mg/kg) or their vehicles were administered intraperitoneally 30 min prior to testing. Diazepam (0.5, 1.5, 2.5 mg/kg) was used as a positive comparator for anxiolytic effect. In comparison with control animals, the percentage of time the rats treated with fluoxetine (5 and 10 mg/kg) and paroxetine (3 and 12 mg/kg) spent in the open arms decreased. The percent of inactive time spent in the open arms also decreased in rats given fluoxetine (5 and 10 mg/kg) and paroxetine (12 mg/kg). Desipramine was inactive on all these parameters. In conclusion, acute treatment with fluoxetine and paroxetine, but not with desipramine, produced a pattern of anxiety behavior. Thus, the pharmacological mechanism appears to be due more to serotonergic than adrenergic neurotransmission. The elevated plus-maze exhibits good sensitivity for detecting anxiogenic effects of antidepressant drugs and the conventional parameters are sufficient and reliable for detecting such effects.</description><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Antidepressants</subject><subject>Anxiety</subject><subject>Behavior, Animal - drug effects</subject><subject>Behavioral psychophysiology</subject><subject>Biological and medical sciences</subject><subject>Desipramine - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Ethological parameters</subject><subject>Fluoxetine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Male</subject><subject>Maze Learning - drug effects</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Paroxetine - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Plus-maze</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Serotonin Uptake Inhibitors - pharmacology</subject><issn>0166-4328</issn><issn>1872-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkUtv3SAQRlHUKrlJ8wO6qbxpVvEtGDC2soqi9CFF6qZdkwEGlSu_CnbU5tcX61rKLl3Bh86MZg6EvGd0zyirPx32xsR9RWmd857S6oTsWKOqUknRviG7zNSl4FVzRs5TOlBKBZXslJwxRVvJqNiRx3vv0c6pGH0Bdpmx8N0y_sE5DHhdTBC3ewGDKxymMEXo1zwORYRcN2Oa0a1x_oUFdvgEa566JZU9POM78tZDl_ByOy_Iz8_3P-6-lg_fv3y7u30oraR8LiUwaoX30oAxwlsrjDSutShQeseqvBBVXPlWGfTGYQPK8UrWVJnGgkd-Qa6Ofac4_l7yULoPyWLXwYDjknTdcMVbKf8LslZWdVM1GWRH0MYxpYheTzH0EP9qRvXqXx909q9X_-tT9p9rPmzNF9Oje6nYhGfg4wZAstD5CIMN6YVrBBdC8MzdHDnMzp4CRp1swMGiCzH_l3ZjeGWMfzChpHw</recordid><startdate>20070125</startdate><enddate>20070125</enddate><creator>Drapier, Dominique</creator><creator>Bentué-Ferrer, Danièle</creator><creator>Laviolle, Bruno</creator><creator>Millet, Bruno</creator><creator>Allain, Hervé</creator><creator>Bourin, Michel</creator><creator>Reymann, Jean-Michel</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20070125</creationdate><title>Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze</title><author>Drapier, Dominique ; Bentué-Ferrer, Danièle ; Laviolle, Bruno ; Millet, Bruno ; Allain, Hervé ; Bourin, Michel ; Reymann, Jean-Michel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-5a10c4ff5babb4fcc4b5bd9ce4e5fd125490737f97befbde8a7d325607b8cafe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Antidepressants</topic><topic>Anxiety</topic><topic>Behavior, Animal - drug effects</topic><topic>Behavioral psychophysiology</topic><topic>Biological and medical sciences</topic><topic>Desipramine - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Ethological parameters</topic><topic>Fluoxetine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Male</topic><topic>Maze Learning - drug effects</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Paroxetine - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Plus-maze</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Serotonin Uptake Inhibitors - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Drapier, Dominique</creatorcontrib><creatorcontrib>Bentué-Ferrer, Danièle</creatorcontrib><creatorcontrib>Laviolle, Bruno</creatorcontrib><creatorcontrib>Millet, Bruno</creatorcontrib><creatorcontrib>Allain, Hervé</creatorcontrib><creatorcontrib>Bourin, Michel</creatorcontrib><creatorcontrib>Reymann, Jean-Michel</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Behavioural brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Drapier, Dominique</au><au>Bentué-Ferrer, Danièle</au><au>Laviolle, Bruno</au><au>Millet, Bruno</au><au>Allain, Hervé</au><au>Bourin, Michel</au><au>Reymann, Jean-Michel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze</atitle><jtitle>Behavioural brain research</jtitle><addtitle>Behav Brain Res</addtitle><date>2007-01-25</date><risdate>2007</risdate><volume>176</volume><issue>2</issue><spage>202</spage><epage>209</epage><pages>202-209</pages><issn>0166-4328</issn><eissn>1872-7549</eissn><coden>BBREDI</coden><abstract>Antidepressants are usually prescribed for the treatment of depression but more recently have also been recommended for the treatment of anxiety disorders. The purpose of this study was to investigate the anxiogenic- or anxiolytic-like effects of an acute administration of antidepressants (serotonergic and noradrenergic compounds) in male Wistar rats submitted to the elevated plus-maze. Fluoxetine (2.5, 5, 10, 15 mg/kg), paroxetine (0.1, 0.5, 3, 12 mg/kg) and desipramine (2.5, 5, 10 mg/kg) or their vehicles were administered intraperitoneally 30 min prior to testing. Diazepam (0.5, 1.5, 2.5 mg/kg) was used as a positive comparator for anxiolytic effect. In comparison with control animals, the percentage of time the rats treated with fluoxetine (5 and 10 mg/kg) and paroxetine (3 and 12 mg/kg) spent in the open arms decreased. The percent of inactive time spent in the open arms also decreased in rats given fluoxetine (5 and 10 mg/kg) and paroxetine (12 mg/kg). Desipramine was inactive on all these parameters. In conclusion, acute treatment with fluoxetine and paroxetine, but not with desipramine, produced a pattern of anxiety behavior. Thus, the pharmacological mechanism appears to be due more to serotonergic than adrenergic neurotransmission. The elevated plus-maze exhibits good sensitivity for detecting anxiogenic effects of antidepressant drugs and the conventional parameters are sufficient and reliable for detecting such effects.</abstract><cop>Shannon</cop><pub>Elsevier B.V</pub><pmid>17095104</pmid><doi>10.1016/j.bbr.2006.10.002</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0166-4328
ispartof Behavioural brain research, 2007-01, Vol.176 (2), p.202-209
issn 0166-4328
1872-7549
language eng
recordid cdi_proquest_miscellaneous_68373955
source ScienceDirect Freedom Collection 2022-2024
subjects Analysis of Variance
Animals
Antidepressants
Anxiety
Behavior, Animal - drug effects
Behavioral psychophysiology
Biological and medical sciences
Desipramine - pharmacology
Dose-Response Relationship, Drug
Enzyme Inhibitors - pharmacology
Ethological parameters
Fluoxetine - pharmacology
Fundamental and applied biological sciences. Psychology
Male
Maze Learning - drug effects
Medical sciences
Neuropharmacology
Paroxetine - pharmacology
Pharmacology. Drug treatments
Plus-maze
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychology. Psychophysiology
Psychopharmacology
Rats
Rats, Wistar
Serotonin Uptake Inhibitors - pharmacology
title Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A30%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20acute%20fluoxetine,%20paroxetine%20and%20desipramine%20on%20rats%20tested%20on%20the%20elevated%20plus-maze&rft.jtitle=Behavioural%20brain%20research&rft.au=Drapier,%20Dominique&rft.date=2007-01-25&rft.volume=176&rft.issue=2&rft.spage=202&rft.epage=209&rft.pages=202-209&rft.issn=0166-4328&rft.eissn=1872-7549&rft.coden=BBREDI&rft_id=info:doi/10.1016/j.bbr.2006.10.002&rft_dat=%3Cproquest_cross%3E68373955%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c503t-5a10c4ff5babb4fcc4b5bd9ce4e5fd125490737f97befbde8a7d325607b8cafe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19526828&rft_id=info:pmid/17095104&rfr_iscdi=true